tecovirimat 200 MG Oral Capsule
- RxCUI
- 2055109
- RxNorm name
- tecovirimat 200 MG Oral Capsule
- Display name
- tecovirimat 200 MG Oral Capsule
- Full name
- tecovirimat 200 MG Oral Capsule
- Term type
- PSN
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:29
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| TPOXX | TECOVIRIMAT MONOHYDRATE | SIGA Technologies, Inc. | fce826ab-4d6a-4139-a2ee-a304a913a253 | 2025-12-31 | Warnings, Adverse reactions | 2055109 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| fce826ab-4d6a-4139-a2ee-a304a913a253 | tecovirimat 200 MG Oral Capsule | PSN | 17 | These highlights do not include all the information needed to use TPOXX ® safely and effectively. See full prescribing information for TPOXX. TPOXX (tecovirimat) capsules, for oral use TPOXX (tecovirimat) injection for intravenous use Initial U.S. Approval: 2018 | 20251231 |
| fce826ab-4d6a-4139-a2ee-a304a913a253 | tecovirimat 200 MG Oral Capsule | SCD | 17 | These highlights do not include all the information needed to use TPOXX ® safely and effectively. See full prescribing information for TPOXX. TPOXX (tecovirimat) capsules, for oral use TPOXX (tecovirimat) injection for intravenous use Initial U.S. Approval: 2018 | 20251231 |